Recombinant Acinetobacter sp. UPF0301 protein ACIAD0353 (ACIAD0353)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please consult your local distributor for precise delivery estimates.
Note: Our standard shipping includes blue ice packs. Dry ice shipping requires advance notification and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a guideline.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and the protein's inherent stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The specific tag type is determined during production. If you require a specific tag, please inform us; we will prioritize its development.
Synonyms
ACIAD0353UPF0301 protein ACIAD0353
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-184
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Acinetobacter baylyi (strain ATCC 33305 / BD413 / ADP1)
Target Names
ACIAD0353
Target Protein Sequence
MTKQYLTHRC LIAPPEMADD FFANTVIYLA RHDDEGAQGL IINRPSGIQV RELLNDLDIE ADHVQPHEVL QGGPLRPEAG FVLHTGQPVW HSSIAVGENL CITTSKDILD AIAHNEGVGR YQIALGYASW TKNQLEGEIS RGDWLICDAD MDLIFNLPYD ERWDAAYKKL GVDRIWLSSE IGHA
Uniprot No.

Q&A

What is Acinetobacter sp. ADP1 and why is it considered an ideal model organism for studying proteins like ACIAD0353?

Acinetobacter sp. ADP1 has emerged as an excellent model organism for genetic studies due to two primary advantages. First, it possesses natural competence, which extends to both plasmid DNA and linear fragments, with genes like comP (encoding a pilus-like protein) being essential for this process. Second, it exhibits a strong natural tendency toward homology-directed recombination .

The natural competence of ADP1 only requires that transformation occurs during exponential growth. Under optimal conditions, ADP1 demonstrates competence levels approximately 10-100 times higher than calcium chloride-treated E. coli (cell−1 μg−1) . These properties enable genetic manipulation through simple addition of linear PCR products to growing cell cultures, followed by incubation and selection on appropriate media, making it an ideal system for studying uncharacterized proteins like ACIAD0353.

What are the fundamental methods for genetic manipulation of Acinetobacter sp. to express recombinant ACIAD0353?

The primary approach for genetic manipulation of Acinetobacter sp. ADP1 involves using splicing PCR techniques to create recombinant constructs. This methodology, initially developed for recombination-proficient E. coli, has been successfully adapted for Acinetobacter with minimal modifications .

Methodology table for genetic manipulation in Acinetobacter sp. ADP1:

StepProcedureKey Considerations
1. IdentificationIdentify target genes and flanking sequences using BLAST or database searchesUse unannotated sequence contigs or specialized databases like ERGO
2. Primer DesignDesign primers to produce ~1kb amplicons of genomic regions flanking the targetFollow Murphy et al. strategy for primer design
3. PCR AmplificationAmplify target regions using designed primersVerify products on agarose gels
4. Splicing PCRJoin PCR products through splicing techniquesFollows the strategy shown in Figure 1A-G of Murphy et al.
5. TransformationAdd spliced PCR products to exponentially growing culturesEnsure cells are in exponential growth phase
6. SelectionPlate on appropriate selective mediaSelect based on antibiotic resistance markers
7. VerificationVerify correct insertion by PCRCompare product lengths against wild-type controls

For expressing recombinant ACIAD0353, this framework can be adapted by inserting expression constructs containing the ACIAD0353 gene with appropriate regulatory elements into the Acinetobacter genome .

How can I optimize transformation efficiency when working with recombinant ACIAD0353 constructs?

Optimizing transformation efficiency for recombinant ACIAD0353 constructs involves several key considerations:

  • Growth phase control: Ensure cells are in exponential growth phase, as natural competence and recombination in ADP1 are expressed only during this period .

  • DNA quality and quantity: Use high-quality PCR products with minimal contaminants. The concentration of DNA should be optimized—typically, 100-500 ng of DNA per transformation is effective.

  • Flanking region length: Use approximately 1 kb flanking regions for homologous recombination. Longer homology regions generally increase transformation efficiency .

  • Selection strategy: Select appropriate antibiotic markers. ADP1 has natural resistance to some β-lactams, so alternative selection agents should be considered. Options include kanamycin, gentamicin, or tetracycline resistance cassettes .

  • Verification method: Use PCR with primers outside the integration region (NF and CR primers) to verify correct insertion, comparing product size against wild-type controls .

What experimental design strategies should be employed when studying the function of uncharacterized proteins like ACIAD0353?

When investigating uncharacterized proteins like ACIAD0353, a robust experimental design is crucial. The following framework provides a systematic approach:

1. Variables identification and control:

  • Independent variables (IVs): These may include expression conditions, genetic backgrounds, or environmental stressors.

  • Dependent variables (DVs): Typically include protein activity, cellular phenotypes, or interaction profiles.

  • Extraneous variables: Must be identified and controlled to avoid confounding results .

2. Hypothesis formulation:

  • Develop null and alternative hypotheses based on bioinformatic predictions or structural similarities to characterized proteins.

  • Ensure hypotheses are specific and measurable .

3. Treatment design:

  • Manipulate independent variables systematically.

  • Determine appropriate levels of treatment (e.g., different expression levels of ACIAD0353).

  • Include proper controls, particularly wild-type strains and empty vector controls .

4. Randomization:

  • Implement randomization to distribute unknown variables evenly across experimental groups.

  • This is essential for establishing causality between manipulated factors and observed outcomes .

5. True experimental design implementation:

  • Use control groups vs. experimental groups with random assignment.

  • Deliberately manipulate variables to observe effects.

  • Ensure random distribution of variables to control for extraneous factors .

This approach allows for systematic investigation of ACIAD0353 function while minimizing the influence of confounding variables and establishing reliable cause-effect relationships.

How can I design effective PCR splicing experiments for modifying the ACIAD0353 gene in Acinetobacter sp.?

Designing effective PCR splicing experiments for ACIAD0353 modification requires careful planning and execution:

Step 1: Primer design strategy
Design primers following this structure:

  • NF/NR primers: Amplify the N-terminal flanking region of ACIAD0353

  • CF/CR primers: Amplify the C-terminal flanking region

  • Include overlapping sequences in lower case on the internal primers to facilitate splicing

Step 2: Cassette selection for gene modification
For marked deletions, use cassettes carrying both positive and negative selection markers:

  • Kan^R^/tdk cassette: Provides kanamycin resistance and sensitivity to azidothymidine (AZT)

  • Kan^R^/sacB cassette: Provides kanamycin resistance and sensitivity to sucrose

Step 3: PCR amplification protocol

  • Amplify N-terminal and C-terminal flanking regions (~1kb each) in separate reactions

  • Amplify the selection cassette

  • Join these products through splicing PCR using the overlapping sequences

Step 4: Verification strategy
After transformation and selection:

  • Use primers outside the targeted region to amplify across the integration site

  • Compare PCR product size against wild-type controls

  • Sequence the junctions to confirm exact integration

This approach enables precise modification of the ACIAD0353 gene, whether for deletion, tagging, or promoter replacement, with high transformation efficiency due to Acinetobacter's natural competence.

What analytical methods are most appropriate for characterizing the function of hypothetical proteins like ACIAD0353?

Characterizing hypothetical proteins like ACIAD0353 requires a multi-faceted analytical approach:

1. Comparative genomic analysis:

  • Identify homologs in related organisms

  • Analyze gene neighborhood and conserved genomic context

  • Examine evolutionary conservation patterns

2. Structural characterization:

  • Protein purification and crystallization

  • Circular dichroism for secondary structure assessment

  • Nuclear magnetic resonance (NMR) for solution structure

3. Interaction studies:

  • Affinity purification coupled with mass spectrometry (AP-MS)

  • Bacterial two-hybrid assays

  • Co-immunoprecipitation experiments

4. Phenotypic analysis of deletion/overexpression strains:

  • Growth curve analysis under various conditions

  • Stress response profiling

  • Metabolic profiling

5. Biochemical characterization:

  • Substrate screening assays

  • Enzymatic activity measurements

  • Post-translational modification analysis

6. Bibliometric data integration:

  • Contextualize findings within the discipline

  • Compare publication patterns and citation metrics

  • Integrate with existing knowledge bases

When interpreting results, it's essential to consider discipline-specific differences in data interpretation, as highlighted by the Academic Analytics Research Center (AARC). This ensures that findings about ACIAD0353 are properly contextualized within the field's publication practices and research culture .

How does the immune response interact with Acinetobacter strains expressing recombinant proteins, and what implications might this have for ACIAD0353 studies?

The immune response to Acinetobacter strains expressing recombinant proteins is complex and has important implications for ACIAD0353 studies:

Serum resistance profile:
Clinical isolates of Acinetobacter spp. demonstrate high serum resistance despite efficient recognition by the complement system . This characteristic affects how recombinant strains might behave in in vivo models or when exposed to serum in vitro.

Complement activation patterns:
Wild-type Acinetobacter strains show distinct complement activation profiles compared to mutant derivatives:

  • Wild-type strains primarily activate the lectin pathway

  • Capsule-negative mutants predominantly activate the classical pathway

  • Both pathways result in C3b and MAC deposition

Immunoglobulin recognition:
Both wild-type and mutant Acinetobacter strains are recognized by human IgG and IgM antibodies at similar levels, indicating that expression of recombinant proteins like ACIAD0353 may not significantly alter antibody recognition .

Implications for ACIAD0353 studies:

  • Expression system design: When designing expression systems for ACIAD0353, researchers should consider how the recombinant protein might affect capsule formation and, consequently, complement activation pathways.

  • In vivo studies: The high serum resistance of Acinetobacter strains may affect the interpretation of in vivo studies with ACIAD0353-expressing strains.

  • Immune evasion mechanisms: Understanding the immune response to Acinetobacter provides insights into potential immune evasion mechanisms that might be relevant if ACIAD0353 is involved in host-pathogen interactions.

  • Purification strategies: The interaction with complement and immunoglobulins may necessitate specific purification strategies when isolating ACIAD0353 from Acinetobacter cultures exposed to serum components.

How can contradictory experimental data regarding ACIAD0353 function be reconciled through advanced experimental approaches?

When faced with contradictory data regarding ACIAD0353 function, advanced experimental approaches can help reconcile these discrepancies:

1. Multi-method validation:
Employ complementary methodologies to verify findings. For example, if protein interaction studies using bacterial two-hybrid and co-immunoprecipitation yield different results, consider adding crosslinking mass spectrometry as a third method to triangulate the true interaction partners.

2. Variable isolation and factorial experimental design:
Implement factorial designs that systematically test combinations of potentially interacting variables. This approach can identify conditional effects that may explain seemingly contradictory observations under different experimental conditions .

3. Strain-specific effects analysis:
Consider genetic background effects by testing ACIAD0353 function in multiple Acinetobacter strains. The example from trastuzumab studies demonstrates how genetic polymorphisms can significantly affect experimental outcomes in unexpected ways .

4. Cellular context dependency:
Examine how the function of ACIAD0353 might be affected by:

  • Growth phase (exponential vs. stationary)

  • Nutrient availability

  • Stress conditions

  • Co-expressed proteins

5. Data integration approach:

Data SourceWeight FactorIntegration Method
Genomic contextHighPhylogenetic profiling
Phenotypic assaysHighMeta-analysis of multiple conditions
Structural predictionsMediumConsensus from multiple algorithms
Protein interactionsMediumNetwork analysis with confidence scoring
Literature reportsVariableCitation analysis and quality assessment

6. Statistical rigor enhancement:

  • Apply appropriate statistical corrections for multiple testing

  • Calculate effect sizes to distinguish statistical from biological significance

  • Implement Bayesian approaches to incrementally update probability estimates as new data emerges

7. External validation:

  • Cross-reference findings with bibliometric patterns in related research areas

  • Consider how disciplinary differences might affect data interpretation

  • Collaborate with research groups using different methodological approaches

By systematically addressing potential sources of experimental variability and applying rigorous validation approaches, contradictory data regarding ACIAD0353 function can often be reconciled, leading to a more coherent understanding of this uncharacterized protein's role.

What are the future research directions for ACIAD0353 and similar uncharacterized proteins in Acinetobacter sp.?

Future research on ACIAD0353 and similar uncharacterized proteins should focus on integrating multiple experimental approaches with computational predictions. The natural competence and genetic tractability of Acinetobacter sp. ADP1 provide an excellent platform for systematic functional characterization . Researchers should consider designing comprehensive experimental plans that encompass genomic, proteomic, and phenotypic analyses while employing rigorous experimental design principles to ensure valid and reproducible results .

The immune response interactions observed in Acinetobacter studies suggest potential roles in host-pathogen interactions that warrant further investigation . Additionally, researchers should leverage disciplinary bibliometric data to contextualize their findings and ensure appropriate comparative frameworks when evaluating experimental outcomes .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.